Aortix™ for Perioperative Kidney Injury

About Procyrion

Procyrion is a private, clinical-stage medical device company developing the Aortix™ device, a novel, minimally invasive circulatory pump for heart failure patients with cardioreal syndrome. Its technology is designed to be deployed percutaneously in under ten minutes to unload the heart and improve kidney perfusion, aiming to break the vicious cycle of cardiorenal syndrome. The company is currently conducting the pivotal DRAIN-HF study in the US and Eastern Europe, positioning it in a multi-billion dollar market with significant unmet need. Procyrion has garnered industry recognition, including being named to Fierce Medtech's Fierce15 list in 2023.

Therapeutic Areas